More on JNJ

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+12.6% Growth)
- Ratings (5.8 Score)
- Holders
- Dividends (2.5% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/16/21 *Est.)
- Ex-Dividend (5/24/2021)
- M&A (12/31/20 *Est)
- Conference (6/3/2021)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

JNJ Income Statement

Click line-items for a historical chart and %
Consolidated Statements of Earnings [Abstract]
Sales to customers (Note 9) 17.82B
Cost of products sold 5.49B
Gross profit 12.33B
Selling, marketing and administrative expenses 4.77B
Research and development expense 2.18B
Interest income -97M
Interest expense, net of portion capitalized 192M
Other (income) expense, net -54M
Restructuring expense 62M
Earnings before provision for taxes on income 5.28B
Provision for taxes on income (Note 5) 1.01B
NET EARNINGS
NET EARNINGS PER SHARE (Note 8)
Basic 1.56
Diluted 1.53
CASH DIVIDENDS PER SHARE 0.8
AVG. SHARES OUTSTANDING
Basic 2.73B
Diluted 2.79B